Quick Answer
Quantum Biopharma Ltd. reported R&D Expense of $2.76 million for fiscal year 2025.
Quantum Biopharma Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $2.76M | -54.6% |
| 2024 | $6.08M | +57.6% |
| 2023 | $3.86M | -44.2% |
| 2022 | $6.91M | +9.2% |
| 2021 | $6.33M | -19.2% |
| 2020 | $7.83M | — |
| 2019 | $0.00 | — |
- Quantum Biopharma Ltd. showed a decrease of -54.6% in R&D Expense compared to the prior fiscal year.
- The most recent figure is from Quantum Biopharma Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: